Geneva, Switzerland

Denis Francois Hochstrasser

This inventor holds 14 USPTO granted patents, plus 12 CIPO patents and 5 EPO patents, primarily in Biomedical Diagnostics. Top assignees: Electrophoretics Limited, University of Geneva, Bio-Rad Laboratories, Inc.. Active years: 1989-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denis Francois Hochstrasser. Retrieved from https://idiyas.com/inventor/denis-francois-hochstrasser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 71.4

 

 

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 66(Granted Patents)


Location History:

  • Collonge-Bellerive, CH (2014)
  • Geneva, CH (1989 - 2015)

Company Filing History:


Years Active: 1989-2015

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Brain Damage Diagnostics
Alzheimer's Disease
Stroke Assays
Transmissible Spongiform Encephalopathies
Polypeptide Characterization
Electrophoresis Gel
Polyacrylamide Gel
Protein Detection
Diagnostic Method
Diagnostic Kit
Biomarkers
Electroblotting
14 patents (USPTO):Explore Patents

Title: Innovations in Diagnosis: The Contributions of Denis Francois Hochstrasser

Introduction: Denis Francois Hochstrasser, an accomplished inventor based in Geneva, Switzerland, has made significant strides in the field of diagnostics, particularly focusing on brain damage-related disorders and Alzheimer's disease. With a remarkable total of 14 patents to his name, Hochstrasser's work has advanced our understanding of critical medical conditions.

Latest Patents: Among his latest innovations are two notable patents. The first patent relates to a diagnostic method for brain damage-related disorders, which involves detecting specific polypeptides or their variants in body fluid samples from subjects. This method is particularly relevant as it distinguishes polypeptide levels in cerebrospinal fluid of deceased patients versus healthy donors, providing a valuable tool for diagnosis. The second recent patent addresses biomarkers for diagnosing Alzheimer's disease, offering a method to assess and monitor the progression of the disease through the detection of specific peptide markers, often utilizing mass spectrometric analysis.

Career Highlights: Denis has worked with reputable organizations such as Electrophoretics Limited and the University of Geneva. His experience in these institutions has not only enriched his professional journey but also contributed to significant advancements in medical diagnostics.

Collaborations: Throughout his career, Hochstrasser has partnered with notable colleagues, including Jean-Charles Sanchez and Willy Vincent Bienvenut. These collaborations have fostered a dynamic exchange of ideas and expertise, enhancing the quality and impact of his inventions.

Conclusion: Denis Francois Hochstrasser stands out as a key figure in the realm of medical diagnostics. His innovative approaches in identifying brain damage-related disorders and Alzheimer's disease through advanced methods are shaping the future of diagnosis. With a strong portfolio of patents and impactful collaborations, Hochstrasser continues to contribute to significant advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…